Drugs / vatreptocog alfa (activated)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01392547 | Jul 2011 → Aug 2012 | congenital hematological disorder, hemophilia A, hemophilia B | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | vatreptocog alfa (activated) | “Single dose of NNC 0078-0000-0007 (vatreptocog alfa (activated)) every 3 months.” NCT01392547 ↗ |
| Known as | NNC 0078-0000-0007 | “Single dose of NNC 0078-0000-0007 (vatreptocog alfa (activated)) every 3 months.” NCT01392547 ↗ |